Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daren Fearon

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Nature Communications|August 12, 2021
Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicaseJoseph A Newman, Alice Douangamath, Setayesh Yadzani, et al.
Communications Chemistry|June 13, 2025
Crystallographic fragment screening reveals ligand hotspots in TRIM21 PRY-SPRY domainYeojin Kim, Aleksandar Lučić, Christopher Lenz, et al.
Journal of Medicinal Chemistry|May 19, 2026
Identification of the Piperidyl Urea Derivative BAY-439 as a Potent and Selective Inhibitor of Human Phospholipase A<sub>2</sub> Group V (hPLA<sub>2</sub>-G5) for the Treatment of Inflammatory PainGernot Langer, Nico Bräuer, Daryl Walter, et al.
Journal of Visualized Experiments : Jove|June 14, 2021
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light SourceAlice Douangamath, Ailsa Powell, Daren Fearon, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
A Structure-Based Computational Pipeline for Broad-Spectrum Antiviral DiscoveryMaria A Castellanos, Alexander M Payne, Jenke Scheen, et al.
Cell Chemical Biology|June 26, 2021
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitorDaniel Zaidman, Paul Gehrtz, Mihajlo Filep, et al.
European Journal of Medicinal Chemistry|October 26, 2024
Rational fragment-based design of compounds targeting the PWWP domain of the HRP familyThibault Vantieghem, Nayyar A Aslam, Evgenii M Osipov, et al.
Nature Communications|May 28, 2021
Exploring protein hotspots by optimized fragment pharmacophoresDávid Bajusz, Warren S Wade, Grzegorz Satała, et al.
Pest Management Science|September 12, 2025
Crystal structure of fatty acid thioesterase A bound by 129 fragments provides diverse development opportunitiesEkaterina Kot, Matteo Paolo Ferla, Patricia Helen Hollinshead, et al.
Journal of Medicinal Chemistry|July 13, 2026
X-ray Crystallography-Guided Design and Synthesis of Cyclopentyl Heteroaryl Carboxylic Acid-Based Inhibitors of the SARS-CoV-2 Nsp3 Macrodomain (Mac1)Xinyu Wang, William T W Butler, James R Donald, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Nature Communications|August 12, 2021
Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicaseJoseph A Newman, Alice Douangamath, Setayesh Yadzani, et al.
Communications Chemistry|June 13, 2025
Crystallographic fragment screening reveals ligand hotspots in TRIM21 PRY-SPRY domainYeojin Kim, Aleksandar Lučić, Christopher Lenz, et al.
Journal of Medicinal Chemistry|May 19, 2026
Identification of the Piperidyl Urea Derivative BAY-439 as a Potent and Selective Inhibitor of Human Phospholipase A<sub>2</sub> Group V (hPLA<sub>2</sub>-G5) for the Treatment of Inflammatory PainGernot Langer, Nico Bräuer, Daryl Walter, et al.
Journal of Visualized Experiments : Jove|June 14, 2021
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light SourceAlice Douangamath, Ailsa Powell, Daren Fearon, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
A Structure-Based Computational Pipeline for Broad-Spectrum Antiviral DiscoveryMaria A Castellanos, Alexander M Payne, Jenke Scheen, et al.
Cell Chemical Biology|June 26, 2021
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 M<sup>pro</sup> inhibitorDaniel Zaidman, Paul Gehrtz, Mihajlo Filep, et al.
European Journal of Medicinal Chemistry|October 26, 2024
Rational fragment-based design of compounds targeting the PWWP domain of the HRP familyThibault Vantieghem, Nayyar A Aslam, Evgenii M Osipov, et al.
Nature Communications|May 28, 2021
Exploring protein hotspots by optimized fragment pharmacophoresDávid Bajusz, Warren S Wade, Grzegorz Satała, et al.
Pest Management Science|September 12, 2025
Crystal structure of fatty acid thioesterase A bound by 129 fragments provides diverse development opportunitiesEkaterina Kot, Matteo Paolo Ferla, Patricia Helen Hollinshead, et al.
Journal of Medicinal Chemistry|July 13, 2026
X-ray Crystallography-Guided Design and Synthesis of Cyclopentyl Heteroaryl Carboxylic Acid-Based Inhibitors of the SARS-CoV-2 Nsp3 Macrodomain (Mac1)Xinyu Wang, William T W Butler, James R Donald, et al.
Pageof 5